McNeill Jonathan — SEC Form 4 filings
SEC reporting owner CIK 1824673. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-18.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-26 to 2026-09-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 9 filings — 192,984 shares, $4,931,185 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 54,648 shares @ $26.72 ($1,460,195) in Dyne Therapeutics, Inc., filed 2024-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Dyne Therapeutics, Inc. (DYN) | Chief Business Officer | 8 | — | 17 legs · 167,865 sh · $4,484,274 | 13 |
| CRESCENT BIOPHARMA, INC. (CBIO) | President and COO | 4 | — | 3 legs · 25,119 sh · $446,911 | 4 |
Form 4 filings — McNeill Jonathan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-18 | 4 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale (S): 731 @ $17.90 · Sale (S): 3,839 @ $16.71 | EDGAR |
| 2026-06-23 | 4 | CRESCENT BIOPHARMA, INC. (CBIO) | Sale (S): 20,549 @ $17.99 | EDGAR |
| 2025-12-17 | 4 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/award (A): 19,507 · Grant/award (A): 6,000 · Grant/award (A): 78,029 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | CRESCENT BIOPHARMA, INC. (CBIO) | Grant/award (A): 172,836 (derivative) @ $0 | EDGAR |
| 2024-08-20 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,400 @ $45.01 · Sale (S): 305 @ $46 | EDGAR |
| 2024-06-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 1,823 @ $31.34 | EDGAR |
| 2024-05-17 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,279 @ $28.20 · Sale (S): 495 @ $28.59 | EDGAR |
| 2024-04-04 | 4 | Dyne Therapeutics, Inc. (DYN) | Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2024-03-13 | 4 | Dyne Therapeutics, Inc. (DYN) | Option exercise (M): 86,159 @ $5.54 · Option exercise (M): 3,841 @ $5.54 · Sale (S): 34,663 @ $25.46 · Sale (S): 54,648 @ $26.72 · Sale (S): 689 @ $27.31 · Option exercise (M): 17,825 @ $5.54 · +5 more | EDGAR |
| 2024-03-11 | 4 | Dyne Therapeutics, Inc. (DYN) | Sale (S): 2,434 @ $25.85 | EDGAR |
| 2024-03-01 | 4 | Dyne Therapeutics, Inc. (DYN) | Option exercise (M): 4,268 @ $0.73 · Sale (S): 4,268 @ $27.50 · Option exercise (M): 24,260 @ $0.73 · Sale (S): 14,103 @ $28.25 · Sale (S): 8,715 @ $29.06 · Sale (S): 1,442 @ $29.70 · +2 more | EDGAR |
| 2024-01-26 | 4 | Dyne Therapeutics, Inc. (DYN) | Option exercise (M): 20,000 @ $0.73 · Sale (S): 19,822 @ $24.52 · Sale (S): 178 @ $25.14 · Option exercise (M): 20,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1824673 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →